Putting disinfectants through their paces using Candida auris dry surface biofilm efficacy testing

Posted

14th January 2019

Research

Candida auris is a high-profile emerging pathogen, which has caused large outbreaks both in the UK and elsewhere. C. auris can causes widespread environmental contamination, and isn’t susceptible to all disinfectants. This new study from Cardiff University extends previous findings by developing a dry surface biofilm efficacy testing model for C. auris. Worryingly, half of the disinfectants tested barely touched the C. auris in the DSB, suggesting that more powerful disinfectants (such as peracetic acid and sodium hypochlorite) should be selected for dealing with C. auris.

Previous studies have shown that a range of disinfectants are effective against C. auris when using conventional suspension testing methodology. However, we know from other studies that the presence of dry surface biofilm (DSB) can reduce the susceptibility of micro-organisms to disinfectants considerably. DSB occur when bacteria and other microbes become attached to surfaces and encased in a protective ‘slime’ layer: this can reduce their susceptibility to disinfectants by 10 to 1000-fold. Therefore, a team at Cardiff University developed a DSB model for C. auris disinfectant testing. 12 commercially-available wipe based disinfectants were tested. Concerning, 50% of the products tested failed to decrease C. auris viability, 58% failed to prevent its transferability, and 75% did not delay biofilm regrowth. Wipes that were effective in reducing C. auris viability and transferability included Clinell’s Universal Wipes, and Clinell’s Sporicidal Wipes (which are based on peracetic acid). Clinell’s Sporicidal Wipes were most effective at preventing re-growth of the biofilm.

This research reinforces that microbes in DSB are considerably less susceptible to disinfectants than microbes in suspension. Caution should be exercised in choosing the appropriate disinfectants for dealing with surfaces potentially contaminated with C. auris, with decisions informed by studies using DSB-based testing methods.

SHARE THIS ARTICLE

Tags

Latest News

Products

Introducing HEXI HUB: A seamless transition in our product line

We’re pleased to announce an update to our product offering…

Products, Research

Innovative solutions for tackling Carbapenemase-producing Enterobacteriaceae (CPE) at King’s College Hospitals

King’s College Hospital NHS Foundation Trust, one of London’s largest…

Products

Gloves Off: reducing unnecessary plastic waste during environmental cleaning and disinfection

In this blog, Dr Phil Norville discusses the momentum-gaining ‘Gloves…

Products

Gloves Off: Navigating SDS sheets and skin safety claims in environmental decontamination products

In this blog, James Clarke (Head of R&D, Science &…